161 related articles for article (PubMed ID: 20358302)
1. The effect of low molecular weight heparin thromboprophylaxis on bleeding complications after gastric cancer surgery.
Jeong O; Ryu SY; Park YK; Kim YJ
Ann Surg Oncol; 2010 Sep; 17(9):2363-9. PubMed ID: 20358302
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
Bergqvist D
Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
[TBL] [Abstract][Full Text] [Related]
3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
[TBL] [Abstract][Full Text] [Related]
5. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of venous thrombosis in cancer patients: practical aspects].
Laza-Achille M; Desruennes E; Di Palma M
Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
[TBL] [Abstract][Full Text] [Related]
7. Prevention of venous thromboembolism in cancer patients.
Kakkar AK; Williamson RC
Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
[TBL] [Abstract][Full Text] [Related]
8. [Heparin and cancer].
Lykke J
Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy with low molecular weight heparin in cancer patients.
Petralia P; Kakkar AK
Eur J Med Res; 2004 Mar; 9(3):119-24. PubMed ID: 15096321
[TBL] [Abstract][Full Text] [Related]
10. Prolonged thromboprophylaxis with low molecular weight heparin after major abdominal surgery.
Rasmussen MS
Curr Opin Pulm Med; 2007 Sep; 13(5):389-92. PubMed ID: 17940482
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin: from the bench to the orthopedic patient.
Turpie AG
Orthopedics; 1997 Feb; 20 Suppl():10-3. PubMed ID: 9048401
[TBL] [Abstract][Full Text] [Related]
12. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis against venous thromboembolism after surgery for cancer.
Moulias S; Bouchon JP; Meaume S
N Engl J Med; 2002 Jul; 347(3):220; author reply 220. PubMed ID: 12124417
[No Abstract] [Full Text] [Related]
14. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
Cunningham RS
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
[TBL] [Abstract][Full Text] [Related]
15. [Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
Hoffman R; Largiadèr F; Brütsch HP
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1179-84. PubMed ID: 1983509
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
17. The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients.
Noble SI; Hood K; Finlay IG
Palliat Med; 2007 Sep; 21(6):473-6. PubMed ID: 17846086
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
Raskob GE
Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation and thrombosis in patients with ovarian malignancy.
von Tempelhoff GF; Dietrich M; Niemann F; Schneider D; Hommel G; Heilmann L
Thromb Haemost; 1997 Mar; 77(3):456-61. PubMed ID: 9065993
[TBL] [Abstract][Full Text] [Related]
20. Perioperative bridging therapy with low molecular weight heparin for patients with inherited thrombophilia and antiphospholipid syndrome on long-term acenokumarol therapy.
Wiszniewski A; Szopiński P; Ratajczak J; Bilski R; Bykowska K
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):34-9. PubMed ID: 21076281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
